Cargando…
Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity
NOD2 is an innate immune receptor that constitutes an important target for the development of small molecule immunopotentiators with great potential to be used as vaccine adjuvants. We report here the results of an in vivo study of the adjuvant properties of a desmuramylpeptide NOD2 agonist SG29 and...
Autores principales: | Guzelj, Samo, Šišić, Marcela, Bizjak, Špela, Frkanec, Leo, Frkanec, Ruža, Jakopin, Žiga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785857/ https://www.ncbi.nlm.nih.gov/pubmed/36559249 http://dx.doi.org/10.3390/pharmaceutics14122755 |
Ejemplares similares
-
Covalently
Conjugated NOD2/TLR7 Agonists Are Potent
and Versatile Immune Potentiators
por: Guzelj, Samo, et al.
Publicado: (2022) -
Discovery
of Desmuramylpeptide NOD2 Agonists with
Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022) -
Structural Fine-Tuning
of Desmuramylpeptide NOD2 Agonists
Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021) -
Adamantane in Drug Delivery Systems and Surface Recognition
por: Štimac, Adela, et al.
Publicado: (2017) -
Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening
por: Guzelj, Samo, et al.
Publicado: (2022)